Search Knowledge Base

7 results for "Alpha Lipoic Acid"

Evidence Search Results semantic · quality-ranked

Quality: 75 2020 PMID: 32356369 DOI: 10.1002/14651858.CD011368.pub2
BACKGROUND: Acne is an inflammatory disorder with a high global burden. It is common in adolescents and primarily affects sebaceous gland-rich areas. The clinical benefit of the topical acne treatment...
Alpha-lipoic acid for diabetic peripheral neuropathy systematic_review cochrane_review
Quality: 77 2024 PMID: 38205823 DOI: 10.1002/14651858.CD012967.pub2
BACKGROUND: Diabetic peripheral neuropathy (DPN) is a frequent complication in people living with type 1 or type 2 diabetes. There is currently no effective treatment for DPN. Although alpha-lipoic ac...
Quality: 62 2024 PMID: 40134249 DOI: 10.31083/IJVNR36623
**Sharifi-Zahabi et al., 2024** | Int J Vitam Nutr Res | Meta Analysis Sharifi-Zahabi Elham, Abdollahzad Hadi. Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review...
Quality: 60 2023 PMID: 37933068 DOI: 10.1097/MD.0000000000035368
BACKGROUND: This systematic review explores the most current evidence regarding the mechanisms of neuropathic pain in patients with different types of diabetes and how this pain affects different func...
Quality: 52 2024 PMID: 38295879 DOI: 10.1016/j.jcjd.2024.01.007
OBJECTIVES: Current medications for diabetic neuropathy (DN) recommended by the American Diabetes Association and American Academy of Neurology do not address the pathologic process of denervation amo...
Quality: 62 2024 PMID: 39339645 DOI: 10.3390/nu16183045
AIM: To investigate the efficacy of Palmitoylethanolamide (PEA, 300 mg), Superoxide Dismutase (SOD, 70 UI), Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg...
Quality: 57 2018 PMID: 29990473 DOI: 10.1016/j.metabol.2018.07.002
OBJECTIVE: This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to summarize the effect of alpha-lipoic acid (ALA) supplementation on glycemic control and lipi...
Quality: 54 2020 PMID: 32370731 DOI: 10.2174/1871530320666200506081407
BACKGROUND: Alpha-lipoic acid (ALA) was used in the treatment of diabetic peripheral neuropathy (DPN) using different routes, doses and treatment durations. The aim of this work is to assess the effic...
Quality: 54 2012 PMID: 22837391 DOI: 10.1530/EJE-12-0555
OBJECTIVE: To evaluate the effects and safety of 300-600 mg α-lipoic acid (ALA) given i.v. for diabetic peripheral neuropathy (DPN). METHODS: We searched the databases of Medline, Embase, and Cochrane...

View full evidence search →